March 17, 2015
A Massachusetts federal judge on Tuesday nixed a lawsuit accusing Novartis Pharmaceuticals Corp. and Genentech Inc. of off-label marketing and providing kickbacks to sell an asthma drug, saying fraud was "probable," but the whistleblower plaintiffs hadn't shown specific violations of the False Claims Act.